Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
may be a member of the chemokine receptor family [RGD, Feb 2006].. Additionally we are shipping CMKLR1 Kits (6) and CMKLR1 Proteins (4) and many more products for this protein.
Showing 10 out of 153 products:
Human Polyclonal CMKLR1 Primary Antibody for WB - ABIN1881215
Ohira, Arita, Omori, Recchiuti, Van Dyke, Serhan: Resolvin E1 receptor activation signals phosphorylation and phagocytosis. in The Journal of biological chemistry 2010
Show all 5 Pubmed References
Human Monoclonal CMKLR1 Primary Antibody for CyTOF, FACS - ABIN4899107
Skrzeczyńska-Moncznik, Wawro, Stefańska, Oleszycka, Kulig, Zabel, Sułkowski, Kapińska-Mrowiecka, Czubak-Macugowska, Butcher, Cichy: Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. in Biochemical and biophysical research communications 2009
Show all 4 Pubmed References
Mouse (Murine) Polyclonal CMKLR1 Primary Antibody for IF (p), IHC (p) - ABIN1715118
Qu, Zhang, Yao, Song, Nikolic-Paterson, Li: Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. in The Journal of pathology 2014
Show all 2 Pubmed References
Human Monoclonal CMKLR1 Primary Antibody for FACS - ABIN4895587
Herová, Schmid, Gemperle, Hersberger: ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. in Journal of immunology (Baltimore, Md. : 1950) 2015
Human Monoclonal CMKLR1 Primary Antibody for FACS - ABIN2473015
Rosenkranz, Klopman: A re-examination of the genotoxicity and carcinogenicity of azathioprine. in Mutation research 1991
Show all 2 Pubmed References
Human Monoclonal CMKLR1 Primary Antibody for FACS - ABIN2473019
Zabel, Silverio, Butcher: Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. in Journal of immunology (Baltimore, Md. : 1950) 2004
Show all 2 Pubmed References
CMKLR1 and GPR1 (show GPR1 Antibodies) were widely expressed in vascular smooth muscle.
Both ALX and ChemR23 were present in human synovium and medial tibial plateau bone obtained following total knee replacement surgery for osteoarthritis.
Results show that ChemR23 is highly expressed in squamous oesophageal cancer tumors and cell lines.
CMKLR1 exacerbated the proliferation and migration of VSMCs by activating ERK1/2 (show MAPK1/3 Antibodies).
We demonstrated that chemerin (show RARRES2 Antibodies) is linked to metabolic syndrome components. Moreover, serum chemerin (show RARRES2 Antibodies) levels were associated significantly with obesity, especially visceral adipose tissue, in subjects with T2DM [type 2 diabetes mellitus].
Study shows that hepatic CMKLR1 mRNA is weakly associated with features of NASH (show SAMSN1 Antibodies) in male patients only.
Our results show that higher levels of circulating chemerin (show RARRES2 Antibodies), CRP (show CRP Antibodies), fibrinogen, and ESR (show ESR1 Antibodies) are associated with an increased risk of developing colorectal cancer
Data show inverse Relationship of the CMKLR1 Relative Expression and Chemerin (show RARRES2 Antibodies) Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin (show INS Antibodies) Resistance
Results indicate that Abeta42 activates CMKLR1, leading to glia cell migration and clearance of Abeta42; and is involved in Abeta (show APP Antibodies) processing and clearance
Gestational obesity and gestational diabetes mellitus may contribute to elevated serum chemerin (show RARRES2 Antibodies). Serum chemerin (show RARRES2 Antibodies) in pregnancy was associated with insulin (show INS Antibodies) resistance and triglycerides. Chemerin (show RARRES2 Antibodies) gene may play a role both in obese and gestational diabetes mellitus patients
These findings support a fundamental biological function for chemerin (show RARRES2 Antibodies)/CMKLR1 to balance osteoblastogenic and adipogenic signaling and thereby contribute to the maintenance of pluripotency in mesenchymal stem cells.
Chemerin (show RARRES2 Antibodies)-CMKLR1 activates Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) and ERK (show EPHB2 Antibodies) pathways and facilitates preadipocyte proliferation, adipogenesis, and angiogenesis. Gax (show MEOX2 Antibodies) weakens the effect of chemerin (show RARRES2 Antibodies) on preadipocyte biofunctions.
CMKLR1 gene deletion attenuates the effects of chronic DHT treatment on ovarian function in experimental PCOS, likely via BMP4 (show BMP4 Antibodies) signaling.
Loss of CMKLR1 exacerbates glucose intolerance and insulin (show INS Antibodies) resistance in mice fed high fat diets.
The chemerin15 (C15) precursor, chemerin, and its receptor, ChemR23, are both upregulated after skin damage and the receptor is expressed by macrophages, neutrophils, and keratinocytes. C15 delivery dampens immediate inflammatory events.
Increased chemerin (show RARRES2 Antibodies) expression in dermal blood vessels may be associated with the development of digital ulcers in systemic sclerosis.
In brown adipose tissue, cold acclimation strongly diminished chemerin (show RARRES2 Antibodies) gene expression, whereas obesogenic diets augmented expression.
Hematopoietic Deletion of Cmklr1 Does not Affect the Development of Insulin (show INS Antibodies) Resistance or nonalcoholic fatty liver disease.
may be a member of the chemokine receptor family
G-protein coupled receptor ChemR23
, G-protein coupled receptor DEZ
, chemerin receptor
, chemokine receptor-like 1
, orphan G-protein coupled receptor, Dez
, resolvin E1 receptor
, G-protein coupled receptor 27
, G-protein coupled chemoattractant-like receptor
, chemokine-like receptor 1
, seven transmembrane helix receptor